aTYR PHARMA INC cotiza a 0.20 USD y tiene una capitalización bursátil de $20M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Pha…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.11 | $-0.11 | $-0.14 |
| Estimado | $-0.10 | $-0.12 | $-0.14 | $-0.18 |
| Sorpresa | — | +8.3% | +21.4% | +22.2% |
| Métrica | ATYR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -40856.3% | -38.6% | -40817.7% |
| Net Margin | -39009.5% | -33.6% | -38975.9% |
| FCF Margin | -32664.7% | -13.9% | -32650.9% |
| ROE | -109.8% | -40.4% | -69.4% |
| ROA | -79.7% | -32.0% | -47.7% |
| Current Ratio | 5.30 | 2.84 | +2.46 |
| Debt / Equity | — | 0.28 | — |